| scholarly article | Q13442814 |
| P2093 | author name string | C Xie | |
| L Peng | |||
| Z-L Gao | |||
| P-P Wang | |||
| G-L Zhang | |||
| B-L Lin | |||
| D-Y Xie | |||
| P2860 | cites work | Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors | Q24537205 |
| FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal | Q24676637 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Smad transcription factors | Q28284775 | ||
| Interferon-α/β and anti-fibroblast growth factor receptor 1 monoclonal antibody suppress hepatic cancer cells in vitro and in vivo | Q28740388 | ||
| Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells | Q34078634 | ||
| Dynamic FoxO transcription factors | Q36889897 | ||
| Many forks in the path: cycling with FoxO. | Q37129798 | ||
| Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model | Q37310677 | ||
| Molecular mechanisms of hepatocellular carcinoma | Q37323726 | ||
| Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model | Q37398716 | ||
| Interferon-β induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PI3K/Akt pathway | Q39636793 | ||
| Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. | Q39677789 | ||
| p38alpha is required for ovarian cancer cell metabolism and survival. | Q39737484 | ||
| The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma | Q39858544 | ||
| p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription | Q39864596 | ||
| Recombinant human IFN-beta affects androgen receptor level, neuroendocrine differentiation, cell adhesion, and motility in prostate cancer cells | Q40085697 | ||
| Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung. | Q40372805 | ||
| Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. | Q40738912 | ||
| Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse | Q40928411 | ||
| Therapy of human ovarian cancer by transfection with the murine interferon beta gene: role of macrophage-inducible nitric oxide synthase | Q40984276 | ||
| Why do so many cancer patients fail to respond to interferon therapy? | Q41480595 | ||
| Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice | Q45854931 | ||
| Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model | Q45875290 | ||
| Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells | Q47794847 | ||
| Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 | ||
| Negative regulation of the forkhead transcription factor FKHR by Akt. | Q52535267 | ||
| Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents | Q58828469 | ||
| Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors | Q64378688 | ||
| Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents | Q64379193 | ||
| Growth-inhibitory activity of interferon-beta against human colorectal carcinoma cell lines | Q69182472 | ||
| Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers | Q71763735 | ||
| Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers | Q73130450 | ||
| Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model | Q79142180 | ||
| FoxO3a mediates transforming growth factor-beta1-induced apoptosis in FaO rat hepatoma cells | Q79720153 | ||
| Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes | Q84184548 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone marrow | Q546523 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 1198-1205 | |
| P577 | publication date | 2013-07-25 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway | |
| P478 | volume | 109 |
| Q90442533 | Activation of the Toll‑like receptor 2 signaling pathway inhibits the proliferation of HCC cells in vitro |
| Q92134661 | Bidirectional and Opposite Effects of Naïve Mesenchymal Stem Cells on Tumor Growth and Progression |
| Q35588431 | Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system |
| Q37187684 | Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis |
| Q42391294 | Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse |
| Q41923781 | Essential role of HCMV deubiquitinase in promoting oncogenesis by targeting anti-viral innate immune signaling pathways |
| Q94362614 | FOXO3a: A Potential Target in Prostate Cancer |
| Q94957197 | Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication |
| Q28071840 | Genetically modified mesenchymal stromal cells in cancer therapy |
| Q34340901 | High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma |
| Q55065274 | Inhibitory effects of interferon-β on hepatocellular carcinoma HepG2 via Akt/STAT phosphorylation. |
| Q53486125 | Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization. |
| Q92798740 | Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities |
| Q59790772 | Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review |
| Q64076402 | Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice |
| Q40641258 | Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway |
| Q60929024 | Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy |
| Q38761193 | Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth |
| Q35399206 | Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling |
| Q36432206 | Primary ovarian cancer cell inhibition by human Wharton's Jelly stem cells (hWJSCs): Mapping probable mechanisms and targets using systems oncology |
| Q28073691 | The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation |
| Q92260888 | The growth inhibitory effect of human gingiva-derived mesenchymal stromal cells expressing interferon-β on tongue squamous cell carcinoma cells and xenograft model |
| Q42654111 | Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype. |
| Q89797616 | p19Arf sensitizes B16 melanoma cells to interferon-β delivered via mesenchymal stem cells in vitro |
Search more.